Literature DB >> 16232085

Reticulocyte hemoglobin measurement--comparison of two methods in the diagnosis of iron-restricted erythropoiesis.

Lothar Thomas1, Susanne Franck, Maren Messinger, Jo Linssen, Marcus Thomé, Christian Thomas.   

Abstract

The aims of this study were to diagnose iron-restricted erythropoiesis (functional iron deficiency) in patients with classic iron deficiency (ID), anemia of chronic disease (ACD) and the combined state of ID/ACD with the use of two hematological methods for the measurement of reticulocyte hemoglobinization. In comparison, the biochemical markers of iron status were determined. We studied 474 anemic patients admitted to hospital with a broad spectrum of diseases. We measured indicators of reticulocyte hemoglobinization. CHr was determined on an Advia 120 hematology analyzer. A Sysmex XE-2100 hematology analyzer was used to determine RET-Y, the forward scatter of fluorescence-labeled reticulocytes, which can also be expressed as the reticulocyte hemoglobin equivalent (RET-H(e)), as well as RBC-Y, the forward scatter of fluorescence-labeled erythrocytes, which can be expressed as the erythrocyte hemoglobin equivalent. Ferritin, soluble transferrin receptor (sTfR) and the sTfR/log ferritin ratio (sTfR-F index) were used as biochemical markers. The comparison of RET-Y with CHr demonstrated an excellent curvilinear relationship between the two parameters. The normal reference range for Ret-Y was 1630-1860 arbitrary units (AU); mathematical transformation to RET-H(e) gave a range of 28.2-35.7 pg. Correlations of biochemical iron markers with RET-H(e) were as weak as with CHr in patients with ACD and acute phase response. In a diagnostic plot to identify iron status, RET-H(e) could replace CHr without any loss of sensitivity or specificity. Patient mismatch analysis between RET-H(e) and CHr in the diagnostic plot demonstrated agreement for 449 of 474 patients (94.4%). Patient specific anemia mismatches were 2.9-6.2%. According to our results, the indicators of reticulocyte hemoglobinization, RET-H(e) and CHr, measure the same phenomenon. RET-H(e) is as valuable as CHr for the diagnosis of iron-restricted erythropoiesis. The combination of RET-H(e) and the sTfR-F index in a diagnostic plot offers an attractive tool for the evaluation of iron status and identification of the progression of ID.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232085     DOI: 10.1515/CCLM.2005.207

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  17 in total

Review 1.  On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery.

Authors:  Manuel Muñoz; José Antonio García-Erce; Jorge Cuenca; Elvira Bisbe; Enrique Naveira
Journal:  Blood Transfus       Date:  2011-11-30       Impact factor: 3.443

2.  Clinical Value of Hypochromia Markers in the Detection of Latent Iron Deficiency in Nonanemic Premenopausal Women.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  J Clin Lab Anal       Date:  2016-02-22       Impact factor: 2.352

Review 3.  An update on iron physiology.

Authors:  Manuel Muñoz; Isabel Villar; José Antonio García-Erce
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

4.  Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.

Authors:  Sarka Davidkova; Timothy D Prestidge; Peter W Reed; Tonya Kara; William Wong; Chanel Prestidge
Journal:  Pediatr Nephrol       Date:  2015-12-14       Impact factor: 3.714

5.  Reticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variants.

Authors:  Å A Sudmann; A Piehler; P Urdal
Journal:  Int J Lab Hematol       Date:  2012-07-06       Impact factor: 2.877

6.  Erythrocyte and Reticulocyte Indices on the LH 750 as Potential Markers of Functional Iron Deficiency.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  Anemia       Date:  2010-06-16

7.  In Response.

Authors:  Matthew A Warner; Nicole R Guinn
Journal:  Anesth Analg       Date:  2021-06-01       Impact factor: 6.627

8.  Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states.

Authors:  C Brugnara; B Schiller; J Moran
Journal:  Clin Lab Haematol       Date:  2006-10

9.  Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients.

Authors:  Aya Eguchi; Takahiro Mochizuki; Misao Tsukada; Koji Kataoka; Yukio Hamaguchi; Shinichiro Oguni; Kosaku Nitta; Ken Tsuchiya
Journal:  Int J Nephrol       Date:  2012-11-01

Review 10.  Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.